Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT04421092 · ClinicalTrials.gov registry record · Phase 3
Efficacy of SLN Block for Chronic Cough
A Phase 3 study, sponsored by Medical University of South Carolina.
- Completed
- Registry status
- Phase 3
- Development phase
- 17
- Enrollment target
NCT04421092 is a Phase 3 study that has completed, run by Medical University of South Carolina. The registered enrollment target is 17 participants.
The verdict
NCT04421092, a Phase 3 study, has completed, sponsored by Medical University of South Carolina.
- COMPLETED
- Registry status
- Phase 3
- Development phase
- 17 participants
- Enrollment target
Study Summary
This is a research study to find out if superior laryngeal nerve blocks are an effective way to reduce cough when compared to placebo (a substance without any medical value). Eligibility for the study include the following: age \>18, cough history suggestive that the nerve to the voice box is overactive, non-smoker, Patients will be followed over time and assigned to either the treatment or placebo group at random. The treatment would be four superior laryngeal nerve blocks and the placebo would be four saline injections (the inactive substance). Study team will measure if the injection improved cough and ask patients to keep a log of symptoms and fill out questionnaires at each visit. After the four injections, patients will follow up in 3 months to see if cough has returned and if so, how severe the cough is.
Interventions
- PROCEDURE Superior laryngeal nerve block
- PROCEDURE Injection of placebo (saline)
- PROCEDURE Injection of steroid-lidocaine mixture
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 17 participants |
| Start Date | 2020-07-22 |
| Est. Completion | 2022-12-30 |
| Phase | Phase 3 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT04421092
The ClinicalTrials.gov registry entry for NCT04421092 describes a study currently listed as completed, categorized as Phase 3. The registered enrollment target is 17 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is Medical University of South Carolina, which has 755 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 3 interventions - of which Superior laryngeal nerve block is the first listed.
NCT04421092 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT04421092 about?
NCT04421092 is a clinical study titled "Efficacy of SLN Block for Chronic Cough". This is a research study to find out if superior laryngeal nerve blocks are an effective way to reduce cough when compared to placebo (a substance without any medical value). Eligibility for the study include the following: age \>18, cough history suggestive that the nerve to the voice box is overac...
What is the current status of trial NCT04421092?
This trial is currently completed. It is a Phase 3 study. The enrollment target is 17 participants. The study started on 2020-07-22. Estimated completion is 2022-12-30.
What interventions are being tested in trial NCT04421092?
The interventions under investigation include: Superior laryngeal nerve block (PROCEDURE), Injection of placebo (saline) (PROCEDURE), Injection of steroid-lidocaine mixture (PROCEDURE).
Who is sponsoring clinical trial NCT04421092?
This trial is sponsored by Medical University of South Carolina, which has 755 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.